These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20517247)

  • 41. [Peculiarities of immunomodulating therapy in an immunocompromised patient with allergies].
    Klin Med (Mosk); 2011; 89(5):60-4. PubMed ID: 22242271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pathogenesis and treatment of patients after polytrauma].
    Donskov VV; Startsev VIu; Movchan KN; Poliushkin SV
    Urologiia; 2011; (1):11-3. PubMed ID: 21500489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cycloferon in complex therapy of chronic brucellosis].
    Smagina AN; Lin'kova IuN; Shul'diakov AA; Liapina EP
    Antibiot Khimioter; 2010; 55(7-8):42-5. PubMed ID: 21140564
    [No Abstract]   [Full Text] [Related]  

  • 44. [Interferon status in the treatment of neuroleptic-resistant patients with paranoid schizophrenia].
    Maruta NA; Rachkauskas GS; Frolov VM; Vysochin EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 1):31-3. PubMed ID: 22677752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Therapeutic efficacy of various formulations of cycloferon in the treatment of infectious mononucleosis in children].
    Kurmaeva DIu; Baranova IP
    Antibiot Khimioter; 2011; 56(9-10):33-6. PubMed ID: 22586902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cycloferon in the treatment of infectious diseases].
    Romantsov MG; Ershov FI; Kovalenko AL
    Antibiot Khimioter; 2008; 53(3-4):36-45. PubMed ID: 18942425
    [No Abstract]   [Full Text] [Related]  

  • 47. [Cycloferon as an agent for the anti-relapse therapy in patients with chronic hyperplastic sinusitis].
    Vasilenko IP; Romantsov MG; Kriukov AI; Grigorian SS; Kovalenko AL
    Antibiot Khimioter; 2013; 58(7-8):17-22. PubMed ID: 24757829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cycloferon in complex therapy management of chronic laryngitis].
    Demchenko EV; Romantsov MG; Grigorian SS; Kovalenko AL
    Antibiot Khimioter; 2013; 58(5-6):24-31. PubMed ID: 24757822
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Interferon status of patients with non-specific ulcerous colitis and its correction with interferon inducers].
    Maev IV; Grigorian SS; Gadzhieva MG; Ovchinnikova NI; Ospel'nikova TP; Kaziulin AN
    Ter Arkh; 2002; 74(2):31-5. PubMed ID: 11899820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cycloferon in emergency prophylaxis of respiratory viral infections and influenza].
    Romantsov MG; Sologub TV; Petrov AIu; Kovalenko AL
    Klin Med (Mosk); 2011; 89(1):51-4. PubMed ID: 21516768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Focal immunophysiotherapy in combined treatment of men with manifestations of papilloma virus infection].
    Kuntsevich LD; Komov NN; Shibaeva EV; Komarova VD; Kopytova TV; Pyshkina EI; Shchelchkova NA
    Urologiia; 2010; (6):58-62. PubMed ID: 21427998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Perspectives of prevention and treatment of herpes symplex with regular recurrence].
    Isakov VA; Ermolenko DK; Isakov DV
    Ter Arkh; 2011; 83(11):44-7. PubMed ID: 22312884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Immunotropic agents in therapy of chronic degenerative diseases of the vulva].
    Sharapova LE; Shul'diakov AA; Liapina EP
    Antibiot Khimioter; 2012; 57(3-4):25-8. PubMed ID: 22993936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Monitoring of side effects and estimation of cycloferon efficacy in treatment of children with frequent and prolonged diseases].
    Lialikov SA; Romantsov MG; Bedin PG; Ermak SIu
    Antibiot Khimioter; 2012; 57(11-12):26-32. PubMed ID: 23700934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cycloferon efficacy in treatment of upper respiratory tract infections: systematic review and meta-analysis].
    Mazina NK; Mazin PV; Khafisianova RK
    Vestn Otorinolaringol; 2019; 84(3):82-88. PubMed ID: 31486434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The treatment of laryngeal papillomatosis with interferon inducers].
    Karimova FS; Ivanchenko GF; Grigorian SS
    Vestn Otorinolaringol; 2000; (5):54-7. PubMed ID: 11051860
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinicoimmunological monitoring of therapy in patients with associated forms of yersiniosis].
    Gordeets AV; Iurusova EN; Smagina AN; Piskunova SL
    Antibiot Khimioter; 2011; 56(5-6):49-53. PubMed ID: 22145231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Efficiency of using cycloferon as part of combined therapy for chronic hepatitis C (a review of multicenter clinical trials)].
    Sologub TV; Romantsev MG; Shul'diakov AA; Lin'kova IuN; Radchenko VG; Kovalenko AL
    Ter Arkh; 2010; 82(10):78-81. PubMed ID: 21341470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Immunomodulator Cycloferon in the comprehensive treatment of patients with acute non-lymphoblastic leukemia].
    Moiseev SI; Abdulkadyrov KM; Bubnova LN; Glazanova TV; Rozanova OE; Pavlova IE; Balashova VA; Kovalenko AL
    Vopr Onkol; 1999; 45(4):405-10. PubMed ID: 10532100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Experimental and clinicolaboratory evaluation of complex therapy efficacy in arboviral infections].
    Romantsov MG; Galimzianov KhM; Lokteva OM; Kovalenko AL; Stepanov AV
    Antibiot Khimioter; 2012; 57(7-8):12-22. PubMed ID: 23350190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.